Serum proteomic profiling identifies transforming growth factor β receptor as a marker of persistent symptoms up to 18 months after mild SARS-CoV-2 infection
- DOI
- 10.1016/j.bbih.2026.101396
- Published
- 2026-12
- Container
- Brain, Behavior, & Immunity - Health
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.bbih.2026.101396,
title = {Serum proteomic profiling identifies transforming growth factor β receptor as a marker of persistent symptoms up to 18 months after mild SARS-CoV-2 infection},
author = {Thor Ueland and Rebecca Jane Cox and Annika E. Michelsen and Elisabeth Berg Fjelltveit and Kuan Yang and Anders Bonnevie and Tuva Dahl and Fan Zhou and Pål Aukrust and Bjørn Blomberg and Kari Otterdal and Bente Halvorsen and Nina Langeland},
year = {2026},
journal = {Brain, Behavior, \& Immunity - Health},
doi = {10.1016/j.bbih.2026.101396},
url = {https://doi.org/10.1016/j.bbih.2026.101396}
}RIS
TY - JOUR TI - Serum proteomic profiling identifies transforming growth factor β receptor as a marker of persistent symptoms up to 18 months after mild SARS-CoV-2 infection AU - Thor Ueland AU - Rebecca Jane Cox AU - Annika E. Michelsen AU - Elisabeth Berg Fjelltveit AU - Kuan Yang AU - Anders Bonnevie AU - Tuva Dahl AU - Fan Zhou AU - Pål Aukrust AU - Bjørn Blomberg AU - Kari Otterdal AU - Bente Halvorsen AU - Nina Langeland PY - 2026 JO - Brain, Behavior, & Immunity - Health DO - 10.1016/j.bbih.2026.101396 UR - https://doi.org/10.1016/j.bbih.2026.101396 ER -
APA
Ueland, T., Cox, R. J., Michelsen, A. E., Fjelltveit, E. B., Yang, K., Bonnevie, A., Dahl, T., Zhou, F., Aukrust, P., Blomberg, B., Otterdal, K., Halvorsen, B., & Langeland, N. (2026). Serum proteomic profiling identifies transforming growth factor β receptor as a marker of persistent symptoms up to 18 months after mild SARS-CoV-2 infection. Brain, Behavior, & Immunity - Health. https://doi.org/10.1016/j.bbih.2026.101396
Source records
- crossref · retrieved 2026-11-09T23:07:34.610Z